查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球体外毒理学测试市场 2023-2030
市场调查报告书
商品编码
1380468

全球体外毒理学测试市场 2023-2030

Global In-Vitro Toxicology Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

预计全球体外毒理学测试市场在预测期内将以 10.5% 的CAGR成长。药物研究支出的大幅成长是推动体外毒理学测试成长的关键因素。由于製药公司研发支出增加以及进入临床前开发阶段的新药数量增加，体外毒理学测试的需求也随之增加。临床前管道产能的显着增加以及人们对体外测试服务优势的认识不断增强，正在推动全球市场的成长。此外，动物试验传统上不断上涨的成本及其社会伦理问题进一步促进了市场的成长。用于评估药物安全性的体外测试方法的重大发展以及这些药物对细胞和组织的潜在影响是市场成长的其他一些贡献者。

为了满足不断增长的需求，主要参与者正在开设或投资新设施。例如，2023 年 4 月，製药和营养辅料供应商罗盖特 (Roquette) 在费城附近开设了新的製药创新中心。这个耗资 2,500 万美元的新中心将成为全球製药和营养保健品製造商的高级培训和合作中心。美国设施专注于优化下一代口服剂型的患者体验，补充了罗盖特在法国和新加坡现有的製药创新中心的尖端研究活动。支持这些培训课程和该中心主要研究项目的是一套最新的製药加工、测试和製造设备。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bio-Rad Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Agilent Technologies Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按技术分類的全球体外毒理学测试市场
    • 细胞培养
    • 高吞吐量
    • 分子影像
    • 组学分析
  • 全球体外毒理学测试市场（依方法）
    • 细胞分析
    • 生化检测
    • 二氧化硅中
    • 离体
  • 全球体外毒理学测试市场（按应用）
    • 系统毒理学
    • 皮肤毒性
    • 内分泌干扰
    • 眼部毒性
    • 其他应用
  • 全球体外毒理学测试市场（按最终用户）
    • 製药与生物技术
    • 诊断
    • 其他最终用户

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Abbott Laboratories
  • Agilent Technolgies, Inc.
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corp.
  • Eurofins Scientific
  • Evotec S.E.
  • Gentronix
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Inc.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
Product Code: OMR2027767

Title: Global In-vitro toxicology testing Market Size, Share & Trends Analysis Report, by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS), by Method (Cellular Assay, Biochemical Assay, In Silica, Ex Vivo), by Application (Systematic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications), by End-User (Pharmaceutical and Biotechnology, Diagnostics, Other End-Users)Forecast Period (2023-2030).

The global in-vitro toxicology testing market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the in-vitro toxicology testing. Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for in-vitro toxicology testing. A significant increase in preclinical pipeline capacity along with growing awareness about the benefits of in-vitro testing services is driving the global market growth. In addition, the traditional rising cost of animal tests as well as their socio-ethical problems is further contributing to the market growth. Significant developments in the in-vitro testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues are some other contributors to the market growth.

To meet the growing demand key players are opening or investing new facilities. For instance, in April 2023, Roquette, a provider of pharmaceutical and nutraceutical excipients, opened its new pharmaceutical innovation center near Philadelphia. The new $25 million center will be an advanced training and collaboration hub for pharmaceutical and nutraceutical manufacturers across the globe. With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette's existing pharma innovation centers in France and Singapore. Underpinning these training sessions and the center's primary research projects is a suite of the latest pharmaceutical processing, testing, and manufacturing equipment.

In the same month, Millipore Sigma has invested $37.5 million to strengthen biosafety testing in Scotland. The investment includes a new 1200-m2 facility in Glasgow that will house molecular biology and sequencing services, and the company will add biosafety testing, analytical development, and viral clearance suites in its current buildings to expand testing capacity.

Segmental Outlook

The global in-vitro toxicology testing market is segmented based on technology, method, application, and end-user. Based on technology, the market is segmented into in cell culture, high throughput, molecular imaging, and OMICS. Based on method, the market is sub-segmented into cellular assay, biochemical assay, in silica, and ex vivo. Based on application, the market is sub-segmented into systematic toxicology, dermal toxicity, endocrine disruption, ocular toxicity, and other applications. Based on end-user, the market is sub-segmented into pharmaceutical and biotechnology, diagnostics, and other end-users.

Cell Culture Holds a Prominent Market Share in the Global In-vitro toxicology testing Market

The cell culture technology segment held considerable share in 2022. The cell cultures provide reproducible results to consistent samples, and serve as excellent models for toxicology assays. Hence, it is highly adopted to perform toxicology testing. This technology further enables early stage drug toxicity testing due to which this technology is gaining popularity & extensive application across the globe.

Regional Outlook

The global in-vitro toxicology testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit highest CAGR in the global in-vitro toxicology testing market. The rising investment by companies from emerging economies in enhancing regional healthcare is a key promoter to the regional market growth. Establishment of new healthcare facilities along with alliances formation with major laboratories is further contributing to the market growth.

North America held Considerable Share in the Global In-Vitro Toxicology Testing Market

North America held considerable share in in-vitro toxicology testing market in 2022. The regional market is driven by the presence of key in-vitro toxicology testing service providers. The rising investments in R&D for the development of novel therapeutics for chronic diseases are further contributing to the market growth. According to EFPIA member associations in 2020, the US has invested $72,412 million in pharmaceutical R&D. Besides, the region has a relatively high disposable income, which enables people to afford expensive drugs and medical treatments. This creates a strong demand for pharmaceutical products in the region; which is further contributing to the regional market growth.

Market Players Outlook

The major companies serving the global in-vitro toxicology testing market include: Abbott Laboratories, Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., and Eurofins Scientific SE among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global in-vitro toxicology testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio-Rad Laboratories
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Agilent Technologies Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global In-vitro Toxicology Testing Market by Technology
    • 4.1.1. Cell Culture
    • 4.1.2. High Throughput
    • 4.1.3. Molecular Imaging
    • 4.1.4. OMICS
  • 4.2. Global In-vitro Toxicology Testing Markey by Method
    • 4.2.1. Cellular Assay
    • 4.2.2. Biochemical Assay
    • 4.2.3. In Silica
    • 4.2.4. Ex Vivo
  • 4.3. Global In-vitro Toxicology Testing Market by Application
    • 4.3.1. Systematic Toxicology
    • 4.3.2. Dermal Toxicity
    • 4.3.3. Endorine Disruption
    • 4.3.4. Occular Toxicity
    • 4.3.5. Other Applications
  • 4.4. Global In-vitro Toxicology Testing Market by End-User
    • 4.4.1. Pharmaceutical and Biotechnology
    • 4.4.2. Diagnostics
    • 4.4.3. Other End-Users

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Agilent Technolgies, Inc.
  • 6.3. BioIVT
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. Catalent, Inc.
  • 6.6. Charles River Laboratories International, Inc.
  • 6.7. Danaher Corp.
  • 6.8. Eurofins Scientific
  • 6.9. Evotec S.E.
  • 6.10. Gentronix
  • 6.11. Laboratory Corporation of America Holdings
  • 6.12. Merck KGaA
  • 6.13. Quest Diagnostics Inc.
  • 6.14. SGS S.A.
  • 6.15. Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 7. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 10. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER END-USER MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 29. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 30. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 35. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 36. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 40. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL EX VIVO IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY METHOD, 2022 VS 2030 ($ MILLION)
  • 8. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR VETERINARY HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR EX VIVO END-USER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 23. US IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. UK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)